These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 25965589

  • 1. Ticagrelor-induced acute generalized exanthematous pustulosis.
    Maybrook RJ, Fischer R, Deibert B, Gillihan R, Laarman R, Fraga G, Aires D, Gollub S.
    Int J Cardiol; 2015 Jul 15; 191():11-2. PubMed ID: 25965589
    [No Abstract] [Full Text] [Related]

  • 2. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.
    Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L, PLATO Study Group.
    Circulation; 2010 Nov 23; 122(21):2131-41. PubMed ID: 21060072
    [Abstract] [Full Text] [Related]

  • 3. Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?
    Harding SA, Holley A, Wilkins B, Fairley S, Simmonds M, Larsen PD.
    Intern Med J; 2017 Nov 23; 47(11):1298-1305. PubMed ID: 28857445
    [Abstract] [Full Text] [Related]

  • 4. Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
    Alexopoulos D, Goudevenos JA, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Parissis H, Ntalas IV, Angelidis C, Petousis S, Vavuranakis M, Hahalis G, Stefanadis C, GRAPE Investigators.
    Int J Cardiol; 2013 Oct 15; 168(6):5329-35. PubMed ID: 23978364
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study.
    Bonello L, Frere C, Cointe S, Laine M, Mancini J, Thuny F, Kerbaul F, Lemesle G, Paganelli F, Guieu R, Arnaud L, Dignat-George F, Sabatier F.
    Int J Cardiol; 2015 Oct 15; 187():502-7. PubMed ID: 25846661
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes.
    Cheng JW.
    Clin Ther; 2012 Jun 15; 34(6):1209-20. PubMed ID: 22521881
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ticagrelor approved for acute coronary syndrome.
    Traynor K.
    Am J Health Syst Pharm; 2011 Sep 01; 68(17):1568. PubMed ID: 21856798
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current Evidence on Platelet P2Y12 Receptor Inhibitors: Is There Still a Role for Clopidogrel in 2015?
    Qutub MA, Chong AY, So DY.
    Can J Cardiol; 2015 Dec 01; 31(12):1481-4. PubMed ID: 26243350
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dyspnea in patients treated with P2Y12 receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registry.
    Alexopoulos D, Xanthopoulou I, Perperis A, Goudevenos J, Hamilos M, Sitafidis G, Kanakakis I, Vavouranakis M, Giannopoulos G, Barampoutis N, Deftereos S, Lekakis J.
    Platelets; 2017 Nov 01; 28(7):691-697. PubMed ID: 28150522
    [Abstract] [Full Text] [Related]

  • 19. Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome.
    Caiazzo G, De Rosa S, Torella D, Spaccarotella C, Mongiardo A, Giampà S, Micieli M, Palella E, Gulletta E, Indolfi C.
    Circ Cardiovasc Interv; 2014 Feb 01; 7(1):104-12. PubMed ID: 24449597
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.